J.P. Morgan Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $135
Express News | Abbott: Advisor™ Hd Grid X Mapping Catheter, Sensor Enabled™, Receives U.S. Food & Drug Administration Clearance, Begins Commercial Launch
Express News | Abbott: Global Focalflex Trial Now Underway for Abbott's Tactiflex™ Duo Ablation Catheter, Sensor Enabled™
Abbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac Mapping
Express News | Abbott : JP Morgan Raises Target Price to $135 From $125
Investors Heavily Search Abbott Laboratories (ABT): Here Is What You Need to Know
Abbott Labs Price Target Raised to $130.00/Share From $125.00 by RBC Capital
Abbott Labs Is Maintained at Outperform by RBC Capital
We Think Abbott Laboratories (NYSE:ABT) Can Manage Its Debt With Ease
Abbott Started at Outperform by Oppenheimer, Diversified Portfolio Cited
Abbott Laboratories Analyst Is Bullish About MedTech, Non-MedTech Growth
A Look Into Abbott Laboratories Inc's Price Over Earnings
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
RBC Capital Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $130
Express News | Oppenheimer Initiates Coverage On Abbott Laboratories With Outperform Rating, Announces Price Target of $130
Oppenheimer Initiates Abbott Laboratories(ABT.US) With Buy Rating, Announces Target Price $130
Abbott Laboratories Analyst Ratings
Express News | Abbott : RBC Raises Target Price to $130 From $125
How Is The Market Feeling About Abbott Laboratories?
Goldman Sachs Adjusts Price Target on Abbott Laboratories to $133 From $126